<DOC>
	<DOCNO>NCT00420459</DOCNO>
	<brief_summary>The purpose study determine effectiveness tolerability aripiprazole treatment child adolescent FXS . We hypothesize aripiprazole effective decreasing aggression , SIB , agitation , interfere repetitive behavior commonly observe individual FXS . We also hypothesize aripiprazole well tolerate .</brief_summary>
	<brief_title>Aripiprazole Fragile X Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Fragile X Syndrome</mesh_term>
	<mesh_term>Problem Behavior</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>1 . Males female age 5 35 year 2 . Body weight great equal 15 kg 3 . Confirmed diagnosis Fragile X Syndrome base upon genetic test result . 4 . Outpatients . 5 . Psychotropic medicationfree least 2 week prior screen laboratory test electrocardiogram . ( Except 5 week fluoxetine 4 week typical atypical antipsychotic administer least 4 week period . ) Exceptions medicationfree status include drug give bedtime target insomnia . Such drug may include melatonin , clonidine , chloral hydrate , diphenhydramine , ramelteon , benzodiazepine , sedativehypnotics . 6 . Clinical Global Impression Scale Severity score ( CGIS ) great equal 4 ( Moderately Ill ) 7 . A score great equal 18 Irritability subscale Aberrant Behavior Checklist ( ABC ) screen baseline . 8 . Mental age great equal 18 month measure Wechsler , revise Leiter , Mullen test 9 . Each subject must good physical health determine screen procedure include detailed medical history , complete physical neurological examination . 1 . DSMIV diagnosis schizophrenia , another psychotic disorder , bipolar disorder alcohol substance abuse within last 6 month . 2 . A significant medical condition heart , liver , renal pulmonary disease , actively treated seizure disorder , determine history , physical examination laboratory test . 3 . Subjects unstable seizure disorder exclude . 4 . Females positive urine pregnancy test . 5 . Evidence prior adequate trial aripiprazole ( define duration great equal 2 week dose least 5 mg per day ) . When evidence prior adequate trial aripiprazole , subject must medicationfree least 2 week prior baseline . 6 . Evidence hypersensitivity aripiprazole ( define allergic response [ e.g. , skin rash ] potentially serious adverse effect [ e.g. , significant tachycardia ] ) . 7 . History neuroleptic malignant syndrome . 8 . Subjects , opinion investigator , unsuitable way participate study include unable comply requirement study reason .</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>April 2012</verification_date>
</DOC>